Uptake of Task-Strengthening for Blood Pressure Control
Hypertension, High Blood Pressure, Cardiovascular Diseases

About this trial
This is an interventional prevention trial for Hypertension
Eligibility Criteria
Inclusion Criteria
- Patients registered to receive care at CHPS zone
- Adults age 40 years and older
- Have BP 140-179/90-100 mm Hg
- Able to provide informed consent
Exclusion Criteria
- Previous diagnosis of diabetes, stroke, heart failure or chronic kidney disease BP>180/100 mm Hg
- Positive urine dipstick for protein
- Pregnant
- Unable to provide informed consent
- Patients with history of stroke, heart failure, diabetes, angina, claudication, and BP>180/100 mm Hg will be referred to a specialist
Sites / Locations
- Kintampo Health Research Centre
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Practice Facilitation Group A
Practice Facilitation Group B
After the first 12 months of usual care (No Practice Facilitation), group A will begin to receive the Practice Facilitation (PF) Strategy at the CHPS compounds in addition to Ghana's National Health insurance and the World Health Organization (WHO) CVD Risk Assessment package.
Group B will receive Usual Care (no PF) between 12-24 months which includes Ghana's National Health Insurance, behavioral counseling and referral to care through the usual care system. After 24 months into the trial, Group B will then receive Practice Facilitation strategy in addition to Ghana's National Health insurance and the World Health Organization (WHO) CVD Risk Assessment package for a duration of another 12 months, as this is a stepped wedge design. During this 12 months period, practice facilitation will end in the Group A arm.